Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.9K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.9K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

475
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
475
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

474
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
474
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

400
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
400
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

356
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
356

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR).

Trials·2026
Same author

Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Intensive care medicine·2025
Same author

The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective Dosing.

Clinical pharmacokinetics·2025
Same author

Medication adherence during the run-in phase of clinical trials: A systematic review of methodological and reporting rigour.

British journal of clinical pharmacology·2025
Same author

A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse Settings.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Evaluation of an optimized intermittent vancomycin dosing regimen in infants.

The Journal of antimicrobial chemotherapy·2025

Related Experiment Video

Updated: Apr 19, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K

Methods for Predicting Warfarin Dose Requirements.

Shamin M Saffian1, Daniel F B Wright, Rebecca L Roberts

  • 1*School of Pharmacy, University of Otago, Dunedin, New Zealand; †Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur; and ‡Department of Surgical Sciences, University of Otago, Dunedin, New Zealand.

Therapeutic Drug Monitoring
|December 31, 2014
PubMed
Summary
This summary is machine-generated.

Warfarin dosing methods incorporating INR feedback or Bayesian forecasting offer more precise predictions. Genotype-driven INR feedback algorithms showed the best precision, though some methods had bias in specific patient groups.

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.5K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.9K

Related Experiment Videos

Last Updated: Apr 19, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.5K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.9K

Area of Science:

  • Pharmacogenomics
  • Pharmacokinetics
  • Clinical Pharmacy

Background:

  • Warfarin dosing requires careful management due to its narrow therapeutic index.
  • Predictive algorithms aim to optimize warfarin dosing for improved patient outcomes.
  • Current methods vary in their reliance on patient characteristics and INR feedback.

Purpose of the Study:

  • To compare the predictive performance of various warfarin dosing methods.
  • To evaluate algorithms based on clinical factors, genotype, and INR feedback.
  • To assess the accuracy and precision of a Bayesian forecasting method.

Main Methods:

  • Analysis of data from 46 patients initiating warfarin therapy.
  • Comparison of 9 dosing tools: 8 algorithms and 1 Bayesian method.
  • Evaluation using bias (mean prediction error) and imprecision (RMSE).

Main Results:

  • Genotype-driven INR feedback algorithms (Horne et al, Lenzini et al) demonstrated superior precision (RMSE 1.16-1.19 mg/d).
  • Lenzini et al's INR feedback algorithms (clinical and genotype) provided unbiased predictions.
  • Bayesian method was unbiased overall but overpredicted high-dose requirements (>8 mg/d).

Conclusions:

  • Warfarin dosing methods incorporating INR response (feedback algorithms, Bayesian) yield unbiased and precise predictions.
  • Genotype-driven INR feedback algorithms offer high precision.
  • Further research is needed to compare clinical endpoints of Bayesian vs. INR-driven algorithms.